Page last updated: 2024-09-04

cilomilast and histamine

cilomilast has been researched along with histamine in 2 studies

Compound Research Comparison

Studies (cilomilast)	Trials (cilomilast)	Recent Studies (post-2010) (cilomilast)	Studies (histamine)	Trials (histamine)	Recent Studies (post-2010) (histamine)
162	13	42	37,718	1,372	3,457

Protein Interaction Comparison

Protein	Taxonomy	cilomilast (IC50)	histamine (IC50)
Histamine H1 receptor	Rattus norvegicus (Norway rat)		0.1585
Histamine H1 receptor	Homo sapiens (human)		0.1585

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bochnowicz, S; Christensen, SB; Gorycki, PD; Hay, DW; Kotzer, CJ; Luttmann, MA; Osborn, RR; Torphy, TJ; Underwood, DC	1
Ezeamuzie, CI	1

Other Studies

2 other study(ies) available for cilomilast and histamine

Article	Year
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Bronchial Spasm; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Guinea Pigs; Histamine; In Vitro Techniques; Leukotriene D4; Muscle Contraction; Nitriles; Ovalbumin; Trachea	1998
Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors. European journal of pharmacology, 2001, Apr-06, Volume: 417, Issue:1-2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline	2001

Article

Year

Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.

The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Bronchial Spasm; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Guinea Pigs; Histamine; In Vitro Techniques; Leukotriene D4; Muscle Contraction; Nitriles; Ovalbumin; Trachea

1998

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.

European journal of pharmacology, 2001, Apr-06, Volume: 417, Issue:1-2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline

2001